Recently, Riedel et al. demonstrated that treatment of mice with IL-33 for 4-consecutive days starting 5-days after doxorubicin protected from glomerulosclerosis, as evaluated on day14 post-doxorubicin injection, when the kidneys of control mice were injured and dysfunctional39. The gene discussed is IL33; the disease is glomerulosclerosis.